Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP191217.RADFPrQw4VZ_7GgosVH2aEf9me2vLb3ghN_5v0ttlZoe0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP191217.RADFPrQw4VZ_7GgosVH2aEf9me2vLb3ghN_5v0ttlZoe0130_assertion type Assertion NP191217.RADFPrQw4VZ_7GgosVH2aEf9me2vLb3ghN_5v0ttlZoe0130_head.
- NP191217.RADFPrQw4VZ_7GgosVH2aEf9me2vLb3ghN_5v0ttlZoe0130_assertion description "[Urokinase plasminogen activator (uPA) and PA inhibitor type 1 (PAI-1) are elevated in acute lung injury, which is characterized by a loss of endothelial barrier function and the development of pulmonary edema.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP191217.RADFPrQw4VZ_7GgosVH2aEf9me2vLb3ghN_5v0ttlZoe0130_provenance.
- NP191217.RADFPrQw4VZ_7GgosVH2aEf9me2vLb3ghN_5v0ttlZoe0130_assertion evidence source_evidence_literature NP191217.RADFPrQw4VZ_7GgosVH2aEf9me2vLb3ghN_5v0ttlZoe0130_provenance.
- NP191217.RADFPrQw4VZ_7GgosVH2aEf9me2vLb3ghN_5v0ttlZoe0130_assertion SIO_000772 21540184 NP191217.RADFPrQw4VZ_7GgosVH2aEf9me2vLb3ghN_5v0ttlZoe0130_provenance.
- NP191217.RADFPrQw4VZ_7GgosVH2aEf9me2vLb3ghN_5v0ttlZoe0130_assertion wasDerivedFrom befree-20140225 NP191217.RADFPrQw4VZ_7GgosVH2aEf9me2vLb3ghN_5v0ttlZoe0130_provenance.
- NP191217.RADFPrQw4VZ_7GgosVH2aEf9me2vLb3ghN_5v0ttlZoe0130_assertion wasGeneratedBy ECO_0000203 NP191217.RADFPrQw4VZ_7GgosVH2aEf9me2vLb3ghN_5v0ttlZoe0130_provenance.